Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Evolus Inc
(NQ:
EOLS
)
16.32
-0.43 (-2.57%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 31, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Evolus Inc
< Previous
1
2
3
4
5
6
7
Next >
Roblox, Under Armour, GoPro, Nuvei And Other Big Stocks Moving Higher On Wednesday
November 08, 2023
U.S. stocks traded mostly lower, with the Nasdaq Composite falling around 20 points on Wednesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
November 08, 2023
Via
Benzinga
Why American Public Education Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket
November 08, 2023
Gainers Heart Test Laboratories, Inc. (NASDAQ: HSCS) shares surged 332% to $0.6455 in pre-market trading after falling over 7% on Tuesday.
Via
Benzinga
Earnings Preview: Evolus
August 01, 2023
Via
Benzinga
5 Analysts Have This to Say About Evolus
July 28, 2023
Via
Benzinga
Evolus Inc. (NASDAQ: EOLS) Highlighted for Surprising Price Action
July 27, 2023
Via
Investor Brand Network
12 Health Care Stocks Moving In Tuesday's After-Market Session
November 07, 2023
Via
Benzinga
Evolus Reports Record Third Quarter 2023 Financial Results and Phase II Data for Extra-Strength 40U Formulation of Jeuveau®
November 07, 2023
From
Evolus
Via
Business Wire
“Extra-Strength” 40U Formulation of Jeuveau® Demonstrates Effects Lasting 26 Weeks in Phase II Data Presented at 2023 ASDS Annual Meeting
November 06, 2023
From
Evolus
Via
Business Wire
Evolus to Participate in November Investor Conferences
November 01, 2023
From
Evolus
Via
Business Wire
Why Shares of Evolus Are Jumping Thursday
July 27, 2023
The stock climbed on record second-quarter revenue and a raise in full-year guidance.
Via
The Motley Fool
Evolus to Report Third Quarter 2023 Results
October 25, 2023
From
Evolus
Via
Business Wire
Final Phase 2 Data Evaluating 40U Dose of PrabotulinumtoxinA-xvfs to be Presented at 2023 ASDS Annual Meeting
October 25, 2023
From
Evolus
Via
Business Wire
7 Must-Own Small-Cap Stocks That Could Outperform the Market
October 08, 2023
If you’re ready to absorb significant risk for the chance of ridiculous upside, these small-cap stocks to buy may be just for you.
Via
InvestorPlace
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 29, 2023
From
Evolus
Via
Business Wire
7 Small-Cap Stocks Analysts Predict Will Double in 2024
September 13, 2023
While small-cap stocks to buy present exceptional risk, they also offer tremendous rewards for intrepid retail investors.
Via
InvestorPlace
Evolus to Participate in September Conferences
August 29, 2023
From
Evolus
Via
Business Wire
Evolus Announces Inducement Grants for New Chief Marketing Officer
August 23, 2023
From
Evolus
Via
Business Wire
Evolus Appoints Tomoko Yamagishi-Dressler as Chief Marketing Officer
August 21, 2023
From
Evolus
Via
Business Wire
Over $15M Bet On Impinj? Check Out These 4 Stocks Insiders Are Buying
August 16, 2023
Although U.S. stocks closed lower on Tuesday, there were a few notable insider trades.
Via
Benzinga
Stonegate Capital Partners Announces Publishing of a Thematic Report - Undervalued Growth Pharma Companies Amidst Healthcare Sector Decline
August 08, 2023
Dallas, Texas--(Newsfile Corp. - August 8, 2023) - Stonegate is pleased to announce the...
Via
Newsfile
Evolus Unveils New Branding for Flagship Product Jeuveau® to Reflect Growing and Evolving Consumers
August 08, 2023
From
Evolus
Via
Business Wire
Evolus Reports Second Quarter 2023 Results and Provides Business Update
August 02, 2023
From
Evolus
Via
Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
July 27, 2023
Via
Benzinga
Why Willis Towers Watson Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
July 27, 2023
Gainers Femasys Inc. (NASDAQ: FEMY) gained 54% to $0.55. Femasys reported a notice of allowance for new U.S. patent application covering use of FemBloc for female permanent birth control.
Via
Benzinga
Comcast, STMicroelectronics, Lam Research, Meta Platforms And Other Big Stocks Moving Higher On Thursday
July 27, 2023
U.S. stocks traded higher, with the Nasdaq Composite gaining around 200 points on Thursday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Evolus Raises Full-Year Revenue Guidance on Record Second Quarter 2023 Revenue
July 27, 2023
From
Evolus
Via
Business Wire
Evolus to Participate in Canaccord Genuity’s 43rd Annual Growth Conference
July 26, 2023
From
Evolus, Inc.
Via
Business Wire
Evolus to Report Second Quarter 2023 Results and Provide Business Update
July 19, 2023
From
Evolus
Via
Business Wire
Twitter Faces Threats From AI and Threads
July 15, 2023
AI is changing the open internet landscape, and Meta's new Threads app is looking to take a bite out of Twitter's audience.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.